Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studies

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|116|4|650-656

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.116, Iss.4, 2015-10, pp. : 650-656

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retraction statement: A double‐blind placebo‐controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : E10-E10

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCH Phase 3 Open‐Label Study

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 248-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

PD Surgery Following CCH

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 259-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 6, 2015-06 ,pp. : 1481-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week‐112 Efficacy and Safety Results of the Open‐Label Long‐Term Extension of a Phase III, Double‐Blind, Randomized, Placebo‐Controlled Trial

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 12, 2015-12 ,pp. : 1627-1636

John Wiley & Sons Inc

Access to resources Recommend Favorite